ヒト肝臓モデル市場：製品・用途別-2025-2030年の世界予測

ヒト肝臓モデル市場は、2023年に22億6,000万米ドルと評価され、2024年には25億3,000万米ドルに達すると予測され、CAGR 12.06％で成長し、2030年には50億3,000万米ドルに達すると予測されています。

ヒト肝臓モデル市場には、研究および治療目的で肝機能をシミュレートするin vitroおよびin vivoモデルの開発と利用が含まれます。これらのモデルは、ヒトの肝臓の反応を模倣することができるため、創薬、前臨床試験、毒性学的研究において不可欠であり、動物実験への依存を減らすことができます。ヒト肝臓モデルの必要性は、特にアルコール消費量の増加、肥満、ウイルス感染に起因する肝臓疾患の有病率の上昇に後押しされています。さらに、製薬業界やバイオテクノロジー業界は、医薬品開発のパイプラインを加速し、肝毒性リスクを評価するために、これらのモデルを多用しています。最終用途は製薬、バイオテクノロジー企業、ヘルスケア部門に及び、調査主は学術研究、臨床試験、再生医療にまで及んでいます。

市場成長は主に、より正確で機能的な肝臓モデルを提供する3Dバイオプリンティングや臓器オンチップ技術など、バイオテクノロジーの進歩による影響を受けています。さらに、動物実験の削減に対する規制当局の支持の高まりは、ヒト肝臓モデルの採用が増加していることと一致しています。個別化医療とプレシジョン・ヘルスケアの拡大には潜在的なビジネスチャンスがあり、肝モデルがオーダーメイドの治療試験を提供する可能性があります。企業は、これらのモデルの生理学的妥当性を高めることに注力し、スケーラビリティと再現性を向上させる技術に投資すべきです。

その可能性にもかかわらず、ヒト肝臓モデル市場は、初期投資コストの高さ、モデル精度の技術的課題、試験管内ですべての肝機能を把握することの複雑さなどの限界に直面しています。また、知的財産権や厳しい規制基準が、参入や技術革新の大きな障壁となることもあります。事業の成長に拍車をかけるには、組織培養の改良と予測分析のための人工知能の統合に研究を集中させるべきです。規制機関との継続的な協力や学際的研究への投資は、市場の潜在力をさらに増幅させることができます。市場の競争は激しいが、モデルの信頼性と適用性を高めるイノベーションの機は熟しており、最先端のソリューションを持つ新規参入者にとって肥沃な土壌となっています。

市場力学：急速に進化するヒト肝臓モデル市場の主要市場インサイトを公開

ヒト肝臓モデル市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 非アルコール性脂肪性肝疾患の有病率の上昇
  • ヒト肝疾患のin vitroモデル化における3Dおよび2Dの新たな動向
  • 肝臓オルガノイドに関する取り組みと意識の高まり
• 市場抑制要因
  • 熟練した訓練を受けた専門家の不足
• 市場機会
  • 創薬活動への注目の高まり
  • アジア太平洋およびラテンアメリカにおけるヘルスケアの潜在的成長
• 市場の課題
  • 複雑なヒトオルガノイドモデルの作成

ポーターの5つの力ヒト肝臓モデル市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ヒト肝臓モデル市場における外部からの影響の把握

外部マクロ環境要因は、ヒト肝臓モデル市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ヒト肝臓モデル市場における競合情勢の把握

ヒト肝臓モデル市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスヒト肝臓モデル市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ヒト肝臓モデル市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ヒト肝臓モデル市場における成功への道筋を描く

ヒト肝臓モデル市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 非アルコール性脂肪肝疾患の有病率の上昇
    • ヒト肝疾患のin vitroモデリングにおける3Dおよび2Dの新たな動向
    • 肝臓オルガノイドに関する取り組みと意識の高まり
  • 抑制要因
    • 熟練した訓練を受けた専門家の不足
  • 機会
    • 創薬活動への注目が高まる
    • アジア太平洋とラテンアメリカにおけるヘルスケアの潜在的成長
  • 課題
    • 複雑なヒトオルガノイドモデルの生成
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ヒト肝臓モデル市場：製品別

• 2Dモデル
• 3Dバイオプリンティング
• 肝臓オルガノイド

第7章 ヒト肝臓モデル市場：用途別

• 創薬
• 教育

第8章 南北アメリカのヒト肝臓モデル市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のヒト肝臓モデル市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのヒト肝臓モデル市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• BioIVT LLC
• Biopredic International
• Cellink Global
• CN Bio Innovations Ltd.
• Emulate Inc.
• InSphero AG
• MIMETAS B.V.
• NeurOmics, Inc.
• Organovo Holdings Inc.
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.
• ZenBio, Inc.

LIST OF FIGURES

• FIGURE 1. HUMAN LIVER MODEL MARKET RESEARCH PROCESS
• FIGURE 2. HUMAN LIVER MODEL MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HUMAN LIVER MODEL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. HUMAN LIVER MODEL MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. HUMAN LIVER MODEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HUMAN LIVER MODEL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HUMAN LIVER MODEL MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HUMAN LIVER MODEL MARKET DYNAMICS
• TABLE 7. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY 2D MODELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY 3D BIO PRINTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY LIVER ORGANOIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. CANADA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. CANADA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CHINA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. CHINA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. INDIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. INDIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ITALY HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ITALY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. POLAND HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. POLAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. QATAR HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. QATAR HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. HUMAN LIVER MODEL MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. HUMAN LIVER MODEL MARKET, FPNV POSITIONING MATRIX, 2023

The Human Liver Model Market was valued at USD 2.26 billion in 2023, expected to reach USD 2.53 billion in 2024, and is projected to grow at a CAGR of 12.06%, to USD 5.03 billion by 2030.

The human liver model market encompasses the development and utilization of in vitro and in vivo models that simulate liver function for research and therapeutic purposes. These models are essential in drug discovery, pre-clinical trials, and toxicological studies due to their capability to mimic human liver responses, thereby reducing dependency on animal testing. The necessity for human liver models is driven by the rising prevalence of liver diseases, notably attributed to increasing alcohol consumption, obesity, and viral infections. Moreover, the pharmaceutical and biotechnology industries heavily employ these models to accelerate drug development pipelines and assess hepatotoxicity risks. Application extends to academic research, clinical trials, and regenerative medicine, with end-use spanning pharmaceutics, biotechnology firms, and healthcare sectors.

Market growth is primarily influenced by advancements in biotechnology, such as 3D bioprinting and organ-on-a-chip technologies, which offer more accurate and functional liver models. Furthermore, growing regulatory support for reducing animal testing aligns with the increasing adoption of human liver models. Potential opportunities lie in the expansion of personalized medicine and precision healthcare, where liver models could offer bespoke treatment testing. Companies should focus on enhancing the physiological relevance of these models and invest in technologies that improve scalability and reproducibility.

Despite its potential, the human liver model market faces limitations, including high initial investment costs, technical challenges in model accuracy, and the complexity of capturing all liver functions in vitro. Also, intellectual property rights and stringent regulatory standards can pose significant barriers to entry and innovation. To spur business growth, research should concentrate on refining tissue cultures and integrating artificial intelligence for predictive analytics. Continuous collaboration with regulatory bodies and investment in interdisciplinary research can further amplify market potential. The nature of the market is competitive yet ripe for innovations that enhance model reliability and applicability, presenting a fertile ground for new entrants with cutting-edge solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Liver Model Market

The Human Liver Model Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence rate of non-alcoholic fatty liver disease
  • Emerging 3D and 2D trends in modeling human liver disease in vitro
  • Rising initiatives and awareness about liver organoids
• Market Restraints
  • Lack of skilled and trained professionals
• Market Opportunities
  • Growing focus on drug discovery activities
  • Potential growth of healthcare in the Asia Pacific and Latin America
• Market Challenges
  • Generation of complex human organoid models

Porter's Five Forces: A Strategic Tool for Navigating the Human Liver Model Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Liver Model Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Human Liver Model Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Liver Model Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Human Liver Model Market

A detailed market share analysis in the Human Liver Model Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Liver Model Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Liver Model Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Human Liver Model Market

A strategic analysis of the Human Liver Model Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Human Liver Model Market, highlighting leading vendors and their innovative profiles. These include BioIVT LLC, Biopredic International, Cellink Global, CN Bio Innovations Ltd., Emulate Inc., InSphero AG, MIMETAS B.V., NeurOmics, Inc., Organovo Holdings Inc., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the Human Liver Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across 2D Models, 3D Bio Printing, and Liver Organoids.
• Based on Application, market is studied across Drug Discovery and Education.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence rate of non-alcoholic fatty liver disease
    • 5.1.1.2. Emerging 3D and 2D trends in modeling human liver disease in vitro
    • 5.1.1.3. Rising initiatives and awareness about liver organoids
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of skilled and trained professionals
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing focus on drug discovery activities
    • 5.1.3.2. Potential growth of healthcare in the Asia Pacific and Latin America
  • 5.1.4. Challenges
    • 5.1.4.1. Generation of complex human organoid models
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Human Liver Model Market, by Product

• 6.1. Introduction
• 6.2. 2D Models
• 6.3. 3D Bio Printing
• 6.4. Liver Organoids

7. Human Liver Model Market, by Application

• 7.1. Introduction
• 7.2. Drug Discovery
• 7.3. Education

8. Americas Human Liver Model Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Human Liver Model Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Human Liver Model Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. BioIVT LLC
• 2. Biopredic International
• 3. Cellink Global
• 4. CN Bio Innovations Ltd.
• 5. Emulate Inc.
• 6. InSphero AG
• 7. MIMETAS B.V.
• 8. NeurOmics, Inc.
• 9. Organovo Holdings Inc.
• 10. STEMCELL Technologies Inc.
• 11. Thermo Fisher Scientific Inc.
• 12. ZenBio, Inc.